RELMADA THERAPEUTICS, INC. (RLMD) Gross Margin
- Gross margin · 12 months: Value 14.94%; Formula and calculation Gross profit / revenue. Period ending 2014-02-28..
Gross margin
Overview →Financial period ending 2014-02-28; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 14.94% | Gross profit / revenue. Period ending 2014-02-28. $473.00 ÷ $3.17K × 100 ≈ 14.94% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 473.00 USD | Gross Profit |
| Revenue | 3.17K USD | |
| Cost of products and services | 2.69K USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2014-02-28 | $473.00 | $3.17K | $2.69K | 14.94% |
| 2013-11-30 | $958.00 | $4.83K | $3.87K | 19.83% |
| 2013-08-31 | $1.09K | $5.13K | $4.04K | 21.31% |
| 2013-05-31 | (m) | (m) | (m) | (m) |
| 2013-02-28 | (m) | (m) | (m) | (m) |
| 2012-11-30 | (m) | (m) | (m) | (m) |
| 2012-08-31 | $2.14K | $7.94K | $5.80K | 26.97% |
| 2012-05-31 | (m) | (m) | (m) | (m) |
| 2012-02-29 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |